BG is investing into new technology to provide greater insights into the world of muscles.
Springbok Analytics offers a cutting-edge, scientifically validated muscle AI analytics platform with wide-ranging applications in life sciences, sports, and health. Their advanced 3D AI technology provides current and predictive analysis of muscles in the body, applicable for elite athletes, sports professionals, physiotherapists, people with disabilities, the elderly and more, to maintain their muscle health now and into the future.
Springbok Analytics was discovered through the FSHD Global Foundation, which is focused on giving life to muscles. This unique access is why this opportunity is available today.
At a Glance Company: BG Medical Ai Syndicate Manager: Boston Global Sector: Space Geography: United States of America Investment Period: Initial term of 5 years Minimum Investment: USD$500k Structure: Unit Trust Investors Eligibility: Professional or Sophisticated (S708) Investors Only Target Equity Raise: USD$5.5m LVR Operating: 0% Application Fee: 1% Fees: 1% pa with a performance fee of 20% over a hurdle of 10% Website: www.bostonglobal.com.au
